Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Opdivo
Opdivo
As Bristol Myers reveals trial failure, AstraZeneca's Imfinzi stays king in stage 3 lung cancer
Fierce Pharma
Mon, 05/13/24 - 11:20 am
Bristol Myers Squibb
Opdivo
Yervoy
clinical trials
non-small cell lung cancer
AstraZeneca
Imfinzi
BMS to cut 2,200 jobs in $1.5B restructuring as Opdivo sales drop in Q1
BioSpace
Thu, 04/25/24 - 11:44 am
Bristol Myers Squibb
earnings
Opdivo
layoffs
5 Successful Phase III Oncology Trials in Q1
BioSpace
Tue, 04/9/24 - 11:50 am
oncology
clinical trials
Bristol Myers Squibb
Opdivo
Yervoy
liver cancer
Pfizer
DLBCL
Adcetris
Asieris
HSIL
APL-1702
cervical cancer
Novocure
non-small cell lung cancer
Roche
Genentech
Tecentriq
esophageal squamous cell carcinoma
Padcev, Keytruda, and Balversa leave little room for Opdivo in urothelial carcinoma
Clinical Trials Arena
Thu, 03/21/24 - 06:41 pm
bladder cancer
urothelial cancer
Merck
Pfizer
Bristol Myers Squibb
Padcev
Keytruda
Balversa
Opdivo
BMS racks up phase III win in liver cancer targeted by AstraZeneca and Roche
BioSpace
Wed, 03/20/24 - 11:51 am
Bristol Myers Squibb
immuno-oncology
Opdivo
Yervoy
liver cancer
AstraZeneca
Roche
Bristol Myers, overshadowed by ADC rival, wins FDA nod for Opdivo combo in bladder cancer
Fierce Pharma
Fri, 03/8/24 - 11:54 am
Bristol Myers Squibb
Opdivo
FDA
bladder cancer
Top 40 Best-Selling Oncology Drugs in 2023 by 2022 Data
Xtalks
Mon, 02/5/24 - 10:17 am
oncology
cancer
Keytruda
Revlimid
Opdivo
Imbruvica
Darzalex
Merck
Bristol Myers Squibb
AbbVie
Janssen
BMS' subcutaneous Opdivo clears first phase 3 trial
Pharmaphorum
Mon, 01/29/24 - 11:06 am
Bristol Myers Squibb
Opdivo
clinical trials
kidney cancer
subcutaneous Opdivo
BMS Builds Case for Opdivo, Yervoy Combo in First-Line Colorectal Cancer
BioSpace
Fri, 12/8/23 - 10:00 am
Bristol Myers Squibb
Opdivo
Yervoy
colorectal cancer
metastatic colorectal cancer
clinical trials
BMS chases Merck/Seagen with first-line bladder cancer filing
Pharmaphorum
Tue, 12/5/23 - 11:53 pm
Bristol Myers Squibb
Opdivo
bladder cancer
urothelial cancer
Merck
Seagen
Merck, BMS Score Separate Late-Stage Victories in Bladder Cancer at ESMO
BioSpace
Mon, 10/23/23 - 05:15 pm
ESMO
Merck
Bristol Myers Squibb
bladder cancer
PD-1 inhibitors
Keytruda
Padcev
Opdivo
ESMO: Bristol Myers' Opdivo chalks up bladder cancer win. But a rival combo casts long shadow
Fierce Pharma
Sun, 10/22/23 - 06:06 pm
ESMO
Bristol Myers Squibb
Opdivo
bladder cancer
Padcev
Keytruda
Merck
BMS, Halozyme score with subcutaneous version of Opdivo
Fierce Pharma
Thu, 10/19/23 - 10:42 pm
Bristol Myers Squibb
Halozyme
Opdivo
clinical trials
Bristol Myers Squibb's Opdivo reign expands with new earlier-stage melanoma nod
Fierce Pharma
Mon, 10/16/23 - 11:45 am
Bristol Myers Squibb
Opdivo
melanoma
FDA
Latest trial win further supports expanded use of Bristol Myers’ Opdivo in lung cancer
BioPharma Dive
Sun, 09/24/23 - 08:54 pm
Bristol Myers Squibb
Opdivo
non-small cell lung cancer
clinical trials
Bristol Myers gets positive opinion from CHMP for Opdivo
Pharmaceutical Business Review
Mon, 07/24/23 - 10:20 am
Bristol Myers Squibb
Opdivo
CHMP
Europe
melanoma
Bristol Myers' Opdivo stages comeback in bladder cancer, teeing up 2 'Merck' showdowns
Fierce Pharma
Wed, 07/12/23 - 09:30 am
Bristol Myers Squibb
Opdivo
bladder cancer
Merck
Sellas celebrates positive Phase I results in lung cancer
Clinical Trials Arena
Thu, 06/29/23 - 11:35 am
Sellas
clinical trials
immunotherapy
Opdivo
mesothelioma
lung cancer
ASCO: Seagen's top-selling drug under threat as Bristol Myers' Opdivo beats Adcetris in lymphoma
Fierce Pharma
Sun, 06/4/23 - 04:31 pm
ASCO 2023 - Seagen
Bristol Myers Squibb
Adcetris
Opdivo
antibody-drug conjugate
Hodgkin's lymphoma
Bristol Myers accuses AstraZeneca of infringing patent on cancer blockbuster Opdivo—again
Fierce Pharma
Tue, 05/2/23 - 11:30 pm
Bristol Myers Squibb
Opdivo
patents
legal
AstraZeneca
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »